Scholar Rock drops Catalent facility from marketing application for muscle weakness drug
Scholar Rock(US:SRRK) Reuters·2026-08-08 05:29核心观点 - Scholar Rock公司宣布将从其向FDA提交的审批申请中移除Catalent位于印第安纳州的制造工厂[1] 监管审批动态 - Scholar Rock公司决定将Catalent的印第安纳州制造工厂从其寻求FDA批准治疗罕见神经肌肉疾病药物的申请中移除[1]